What happens when you stop Mounjaro or Wegovy? Learn why weight regain can occur, what the research shows and how to maintain weight loss after stopping.
What happens when you stop Mounjaro or Wegovy?
If you have lost weight with Mounjaro or Wegovy, you may eventually wonder what happens when you stop treatment.
Will the weight stay off? Will your appetite come back? How quickly can weight regain happen? And is there a way to maintain your weight loss after stopping weight loss injections?
These are important questions because Mounjaro (tirzepatide) and Wegovy (semaglutide) are not simply medicines that make people lose weight and then permanently change the body's underlying biology.
They work while they are being taken. When treatment is stopped, the appetite-regulating effects of the medication gradually wear off. For some people, this can be followed by increased hunger, increased food intake and weight regain.
Clinical research has demonstrated that weight regain after stopping GLP-1-based weight-management medication is common. This does not mean that Mounjaro or Wegovy has "failed". Rather, it reflects the fact that obesity and excess weight are complex, chronic conditions involving biological, metabolic, behavioural and environmental factors.
If you are currently considering treatment, our guide to injections for weight loss explains how Mounjaro and Wegovy work, who may be eligible and why medication should form part of a wider weight-management plan.
Will I gain weight after stopping Mounjaro or Wegovy?
You may regain some or all of the weight you lost after stopping Mounjaro or Wegovy.
However, the amount of weight regained varies from person to person.
Some people may maintain a significant proportion of their weight loss, while others may regain a substantial amount. Factors such as your starting weight, amount of weight lost, diet, physical activity, appetite, metabolic health and whether another weight-management strategy is introduced can all influence what happens after treatment stops.
Importantly, stopping treatment does not mean that everyone immediately returns to their previous weight.
Weight regain tends to occur progressively rather than overnight.
Research into semaglutide provides particularly useful evidence about what can happen after treatment is discontinued.
What does the research say about stopping Wegovy?
One of the most frequently cited studies is the STEP 1 trial extension, which examined what happened after people stopped taking semaglutide 2.4 mg.
During the original 68-week treatment period, participants receiving semaglutide lost an average of 17.3% of their body weight.
After semaglutide was discontinued, participants regained an average of 11.6 percentage points of body weight over the following year.
In other words, approximately two-thirds of the weight they had previously lost was regained during the year after stopping treatment.
At the end of the two-year observation period, participants had maintained an average net weight loss of 5.6% from their original baseline.
This is one of the clearest pieces of evidence answering the question: "Does weight come back after stopping Wegovy?"
For many people, some weight regain is likely.
It also demonstrates why weight-management treatment should not necessarily be viewed as a short-term course followed by an automatic return to previous habits.
What happens when you stop Mounjaro?
Mounjaro contains tirzepatide, which acts on both GIP and GLP-1 receptors.
Like semaglutide, tirzepatide can reduce appetite and food intake while helping people feel fuller for longer. Once treatment is discontinued, these pharmacological effects gradually diminish.
Clinical evidence from the SURMOUNT-4 trial provides important information about stopping Mounjaro.
Participants who had received tirzepatide for 36 weeks were subsequently assigned either to continue tirzepatide or switch to placebo.
Those who continued treatment maintained and further improved their weight reduction, whereas those who stopped tirzepatide and switched to placebo experienced substantial weight regain. By week 88, continued treatment was associated with significantly better maintenance of weight loss.
A later analysis of SURMOUNT-4 found that 82% of participants who had achieved clinically meaningful weight reduction regained at least 25% of their initial weight reduction within one year of withdrawing tirzepatide. Greater weight regain was also associated with a greater reversal of some cardiometabolic improvements achieved during treatment.
So, if you are asking "will I gain weight after stopping Mounjaro?", the evidence suggests that weight regain is a significant possibility.
Why do you regain weight after stopping Mounjaro or Wegovy?
The reason is more complicated than simply "eating too much".
Weight regulation is controlled by a sophisticated interaction between the brain, digestive system, hormones, appetite signals, energy expenditure and environmental factors.
Mounjaro and Wegovy alter some of these signals while you are taking them.
1. Your appetite may increase
One of the most noticeable changes after stopping a GLP-1 medication can be the return of hunger.
While taking Wegovy or Mounjaro, many people experience:
- Reduced appetite
- Earlier feelings of fullness
- Less food noise
- Smaller portion sizes
- Fewer cravings
- Reduced overall food intake
After stopping treatment, these effects may diminish.
You may therefore notice that you feel hungrier or think about food more frequently than you did while taking the medication.
2. Satiety signals change
Semaglutide and tirzepatide influence hormonal pathways involved in appetite and satiety.
Wegovy acts primarily through the GLP-1 pathway, while Mounjaro acts through both GIP and GLP-1 pathways.
When the medication is withdrawn, its effects on these pathways are no longer being maintained at the same therapeutic level.
As a result, maintaining the same reduced food intake may become more difficult.
3. The body responds to weight loss
Weight loss itself can trigger biological responses that encourage the body to regain weight.
After significant weight loss, the body can respond by increasing hunger and reducing energy expenditure. These mechanisms are part of the body's natural regulation of energy balance.
This is one reason why long-term weight maintenance can be difficult even when someone is highly motivated.
The evidence from semaglutide withdrawal supports this biological explanation. Researchers concluded that the substantial weight regain following treatment withdrawal reinforces the chronic nature of obesity and the potential need for ongoing treatment to maintain improvements.
How quickly do you gain weight after stopping Mounjaro or Wegovy?
There is no fixed timeline that applies to everyone.
You will not necessarily gain weight immediately after your final injection.
Mounjaro and Wegovy have relatively long durations of action, meaning their effects do not disappear instantly. However, as the medication leaves your system, appetite and other effects may gradually change.
Weight regain can therefore develop over weeks and months.
The research does not support a simple rule such as "you will regain X kilograms after X weeks". Individual responses are considerably more complicated.
A recent systematic review and meta-analysis found that weight regain after stopping weight-management medication is common, with newer and more effective incretin-based medicines showing particularly substantial regain after discontinuation.
Another recent analysis of clinical trials estimated that around 60% of weight lost during GLP-1 receptor agonist treatment was regained one year after stopping, although individual results varied and the available studies had limitations.
Does everyone regain all the weight after stopping Mounjaro or Wegovy?
No.
It is important not to interpret clinical trial results as a prediction of exactly what will happen to you.
Some people maintain a meaningful amount of their weight loss after stopping treatment.
In the STEP 1 extension, for example, participants who had taken semaglutide retained an average net weight loss of 5.6% from baseline one year after treatment withdrawal, despite regaining much of the weight they had initially lost.
Your outcome may be different depending on:
- How much weight you initially lost
- Your starting BMI
- How long you used treatment
- Your appetite after stopping
- Your eating patterns
- Your physical activity
- Your metabolic health
- Other medicines you take
- Whether you continue receiving clinical support
- Whether another treatment is introduced
The important point is that weight regain is common, but complete weight regain is not inevitable.
Is Mounjaro withdrawal the same as Mounjaro weight regain?
Not exactly.
The term "Mounjaro withdrawal" can make it sound as though stopping tirzepatide causes a traditional withdrawal syndrome.
For most patients, the bigger concern is not a classic withdrawal syndrome. Instead, it is what happens when the medication's appetite and metabolic effects are no longer present.
You may notice:
- Increased hunger
- Increased appetite
- Larger portions becoming easier to eat
- More frequent food cravings
- Changes in fullness
- Gradual weight regain
If you experience significant changes after stopping treatment, speak to your prescriber rather than restarting, changing doses or switching medicines without clinical advice.
Is Wegovy withdrawal the same as Mounjaro withdrawal?
Again, the main issue is usually loss of treatment effect rather than a conventional withdrawal syndrome.
Wegovy contains semaglutide, while Mounjaro contains tirzepatide.
Both can influence appetite and food intake, but they do so through somewhat different hormonal pathways.
If you are considering switching between treatments, this should be discussed with a qualified prescriber.
Our guide comparing Mounjaro and Wegovy explains some of the differences between the two medicines, including how they work, dosing, side effects and treatment considerations.
How can you maintain weight after stopping Mounjaro or Wegovy?
If you want to stop treatment, the goal should not simply be to stop the medication and hope that your previous habits will maintain the result.
A structured maintenance plan may be more appropriate.
1. Speak to your prescriber before stopping
Do not make changes to your prescription without discussing them with your healthcare professional.
Your prescriber can review:
- Your current weight
- Your weight-loss progress
- Your BMI
- Your appetite
- Your medical history
- Any side effects
- Other medications
- Your long-term weight-management goals
Depending on your circumstances, continuing treatment, changing treatment or stopping medication may all be considered.
2. Continue prioritising protein
Protein can help support muscle mass during weight loss and may contribute to satiety.
Good sources include:
- Eggs
- Fish
- Lean meat
- Greek yoghurt
- Cottage cheese
- Beans
- Lentils
- Tofu
- Other protein-rich foods
Your nutritional requirements will vary according to your body size, activity level, age and health.
3. Eat high-fibre foods
Fibre-rich foods can help create more satisfying meals.
Consider regularly including:
- Vegetables
- Fruit
- Wholegrains
- Beans
- Pulses
- Nuts and seeds
The aim is not to create an extremely restrictive diet.
Instead, focus on eating patterns that you can realistically maintain over the long term.
4. Maintain physical activity
Exercise can help support weight maintenance, cardiovascular health, metabolic health and muscle preservation.
A combination of aerobic activity and resistance training can be useful.
Resistance exercise is particularly valuable during and after weight loss because preserving muscle mass is an important component of maintaining healthy body composition.
5. Monitor your weight without becoming obsessed with the scales
Regular monitoring can help identify trends early.
A small increase in weight does not necessarily mean treatment has failed.
However, consistent upward movement over several weeks may be a useful signal to review your nutrition, activity levels and treatment plan with your healthcare professional.
Can you stop Mounjaro or Wegovy and keep the weight off?
Yes, it is possible, but it can be difficult.
The evidence suggests that many people regain a substantial proportion of their lost weight after stopping treatment.
This is why modern obesity treatment increasingly focuses on long-term weight management rather than simply achieving an initial weight-loss target.
A person might successfully lose 15 or 20 kg with medication, but the next challenge is maintaining that reduction when appetite-regulating treatment is withdrawn.
For some people, this may involve continuing pharmacological treatment.
For others, it may involve a structured lifestyle programme, alternative treatment or a combination of approaches.
There is no universal answer.
Should you taper Mounjaro or Wegovy?
Do not attempt to create your own tapering schedule.
The correct approach to stopping or changing a prescription medicine depends on the individual medicine, your circumstances and your prescriber's clinical judgement.
If you are thinking about coming off Mounjaro or Wegovy because you have reached your target weight, are experiencing side effects, are concerned about cost or simply want to stop treatment, speak to your prescriber first.
A clinician can help determine whether stopping is appropriate and what your longer-term weight-management strategy should be.
If side effects are influencing your decision, our detailed guide to weight loss injection side effects explains the common and more serious adverse effects associated with medicines such as Mounjaro and Wegovy.
What if I regain weight after stopping Mounjaro or Wegovy?
If you regain some weight, do not assume that you have failed.
Weight regain after stopping anti-obesity medication is a recognised clinical phenomenon.
It can happen even when someone continues making efforts with diet and exercise.
The most important step is to address the situation early.
Your healthcare professional may review your:
- Current BMI
- Weight trajectory
- Appetite
- Diet
- Activity
- Sleep
- Medical conditions
- Medication
- Previous response to treatment
They can then help determine the most appropriate next step.
This may include restarting or continuing treatment where clinically appropriate, considering an alternative medication or focusing on a structured weight-maintenance programme.
What happens to your appetite after stopping Mounjaro or Wegovy?
This is one of the most common concerns among people considering stopping weight loss injections.
While taking Mounjaro or Wegovy, you may become accustomed to feeling less hungry and becoming full after smaller amounts of food.
After stopping, that experience can change.
Some people notice that:
- Hunger returns
- Portions become larger
- Cravings become more noticeable
- Food thoughts increase
- Snacking becomes easier
- Fullness does not last as long
This does not necessarily happen to the same degree in everyone.
However, the return of appetite is one reason why maintaining weight loss can become more challenging after GLP-1 treatment is discontinued.
Can you regain muscle or fat after stopping Mounjaro or Wegovy?
Weight regained after treatment may consist of both fat mass and lean mass, although the exact composition varies between individuals.
This is why weight management should not focus solely on the number shown on the scales.
Maintaining adequate protein intake and incorporating resistance training can help support muscle preservation.
A healthcare professional or appropriately qualified nutrition professional can help you develop a plan suited to your individual needs.
Is weight regain after Mounjaro or Wegovy a sign that the medication did not work?
No.
This is an important distinction.
If someone loses substantial weight while taking Mounjaro or Wegovy and then regains some weight after stopping, it does not mean the medication was ineffective.
The medication may have worked exactly as intended while it was being used.
The challenge is that the underlying biological drivers of weight regulation do not necessarily disappear simply because someone has lost weight.
The STEP 1 findings specifically support the concept that obesity is a chronic condition and that ongoing treatment may be required for some people to maintain weight and associated health improvements.
Is long-term treatment with Mounjaro or Wegovy necessary?
For some people, potentially yes.
Weight-management medicines should not necessarily be viewed like a short course of antibiotics where treatment ends and the underlying condition has been permanently resolved.
For people living with obesity, long-term treatment may be appropriate when the benefits continue to outweigh the risks and treatment remains clinically suitable.
This does not mean everyone needs to take Mounjaro or Wegovy indefinitely.
Treatment should be reviewed regularly.
Your clinician can consider your response, side effects, health status, weight trajectory and personal goals when deciding whether treatment should continue.
What if I want to switch from Mounjaro to Wegovy?
Switching from one weight-management medicine to another should be medically supervised.
Mounjaro and Wegovy are different medicines, and the appropriate dose and timing depend on your individual circumstances.
Do not take both medicines together or attempt to create your own switching schedule.
If you are considering changing treatment because you are experiencing side effects, have reached a weight-loss plateau or are unhappy with your current results, discuss this with your prescriber.
What if I stop because Mounjaro or Wegovy is causing side effects?
Side effects can occur with both medicines.
Common side effects associated with GLP-1-based weight-management treatments can include nausea, vomiting, diarrhoea, constipation and abdominal discomfort.
If side effects are affecting your quality of life, you should speak to your prescriber.
Do not simply increase, decrease or restart your dose without professional advice.
For more information, read our guide to weight loss injection side effects.
The bottom line: what happens when you stop Mounjaro or Wegovy?
Stopping Mounjaro or Wegovy can lead to increased appetite and weight regain.
Clinical trials have shown that a substantial proportion of weight lost during treatment may be regained after medication is withdrawn. In the STEP 1 semaglutide extension, participants regained approximately two-thirds of their previous weight loss over one year. Studies of tirzepatide have also demonstrated substantial weight regain after treatment withdrawal.
However, weight regain is not the same as treatment failure.
Mounjaro and Wegovy can be effective tools for managing obesity and excess weight, but maintaining the result requires a long-term strategy.
For some people, that may involve ongoing medication. For others, a carefully planned transition away from medication may be appropriate.
The key is to avoid treating stopping medication as the end of your weight-management journey.
Instead, it should be part of a planned discussion with your healthcare professional about how to maintain your progress safely and sustainably.
Frequently Asked Questions
Will I gain all the weight back after stopping Mounjaro?
Not necessarily. However, clinical research shows that substantial weight regain is common after stopping tirzepatide. How much weight you regain will vary depending on your individual circumstances and what happens after treatment is discontinued.
Will I gain weight after stopping Wegovy?
Many people regain some weight after stopping Wegovy. In the STEP 1 extension, participants regained an average of approximately two-thirds of their previous weight loss during the year after semaglutide treatment was withdrawn.
How long after stopping Wegovy does weight come back?
There is no exact timeframe. Weight regain can occur progressively over weeks and months as the effects of semaglutide wear off and appetite regulation changes.
How long after stopping Mounjaro do you gain weight?
There is no fixed timeline. Some people may notice increased hunger relatively soon, while measurable weight regain may develop progressively over subsequent months.
Does stopping Mounjaro cause withdrawal?
Stopping Mounjaro is not generally described as causing a conventional withdrawal syndrome. The more important concern is the loss of its appetite-regulating and weight-management effects, which can contribute to increased hunger and weight regain.
Does Wegovy cause rebound weight gain?
Weight regain after stopping Wegovy is well documented in clinical research. It is sometimes described as "rebound weight gain", although the more precise clinical term is weight regain following treatment withdrawal.
Can I keep the weight off after stopping Mounjaro?
It is possible, but it can be challenging. A structured approach involving nutrition, physical activity, appetite management and ongoing clinical support may improve the chances of maintaining weight loss.
Can I keep the weight off after stopping Wegovy?
Some people maintain part of their weight loss, but many regain a significant proportion. Your long-term maintenance strategy should be discussed with your healthcare professional.
Should I stop Mounjaro if I have reached my goal weight?
Do not stop prescription treatment without discussing it with your prescriber. Reaching a target weight does not automatically mean that the underlying reasons for weight gain have disappeared.
Should I stop Wegovy once I reach my target weight?
Not necessarily. Your clinician should review whether continuing treatment, changing treatment or stopping treatment is appropriate based on your individual health and weight-management goals.
Supporting long-term weight management with SynovaMed
If you are taking Mounjaro or Wegovy, considering starting treatment or thinking about stopping, professional clinical support can help you make informed decisions.
SynovaMed provides clinically supervised weight management, including assessment and ongoing support for eligible patients.
Our approach is not simply about supplying a prescription. Treatment should be considered as part of a broader strategy involving nutrition, physical activity, sustainable lifestyle changes and regular clinical review.
You can also explore our guide to Mounjaro and Wegovy to understand how the two treatments compare.
If you are concerned about side effects, our weight loss injection side effects guide provides further information about what to expect and when to seek medical advice.
For patients who are interested in oral alternatives, our guide to Foundayo (orforglipron) explains the newer once-daily weight-management tablet and how it differs from injectable treatments.
Medical disclaimer
This article is for general educational purposes and does not replace personalised medical advice, diagnosis or treatment. Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription medicines and are not suitable for everyone. Do not stop, restart, change or combine prescription medicines without discussing this with an appropriately qualified healthcare professional. Individual results vary, and weight regain after treatment withdrawal is not inevitable in every person.